Hantz Financial Services’s Maravai LifeSciences MRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-21
Closed 2410
2025
Q2
$0 Hold
21
﹤0.01% 2257
2025
Q1
$0 Hold
21
﹤0.01% 1878
2024
Q4
$0 Hold
21
﹤0.01% 1172
2024
Q3
$0 Hold
21
﹤0.01% 1147
2024
Q2
$0 Sell
21
-101
-83% -$872 ﹤0.01% 1195
2024
Q1
$1K Sell
122
-19
-13% -$129 ﹤0.01% 1139
2023
Q4
$1K Sell
141
-10,357
-99% -$66.9K ﹤0.01% 1084
2023
Q3
$105K Buy
10,498
+758
+8% +$8.32K ﹤0.01% 589
2023
Q2
$121K Buy
9,740
+74
+0.8% +$999 ﹤0.01% 567
2023
Q1
$135K Buy
9,666
+1,398
+17% +$20.1K ﹤0.01% 560
2022
Q4
$118K Buy
8,268
+432
+6% +$6.8K ﹤0.01% 565
2022
Q3
$200K Buy
7,836
+589
+8% +$14.8K 0.01% 517
2022
Q2
$206K Buy
7,247
+795
+12% +$25.2K 0.01% 510
2022
Q1
$228K Buy
6,452
+1,340
+26% +$44.9K 0.01% 516
2021
Q4
$214K Buy
5,112
+984
+24% +$39.9K 0.01% 504
2021
Q3
$203K Buy
4,128
+869
+27% +$42.4K 0.01% 491
2021
Q2
$136K Buy
3,259
+1,535
+89% +$59.5K 0.01% 495
2021
Q1
$61K Buy
1,724
+636
+58% +$21.1K ﹤0.01% 516
2020
Q4
$31K Buy
+1,088
New +$30.3K ﹤0.01% 508

Other funds holding MRVI

Hantz Financial Services's MRVI Position: Q3 2025 in Review

Hantz Financial Services sold out of Maravai LifeSciences (MRVI) in Q3 2025, closing a stake of 21 shares.

Hantz Financial Services first reported a position in MRVI in Q4 2020 and held it in 19 quarters. The position peaked at $228K in Q1 2022. 160 funds tracked by Wall St. Rank hold MRVI as of Q3 2025.

  • Hantz Financial Services reported no remaining Maravai LifeSciences position as of Q3 2025 after selling out during the quarter.
  • Hantz Financial Services sold 21 Maravai LifeSciences shares in Q3 2025.
  • Hantz Financial Services first reported a position in Maravai LifeSciences in Q4 2020 and held it in 19 quarters.
  • Hantz Financial Services's Maravai LifeSciences position peaked at $228K in Q1 2022.
  • 160 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2025.

Based on Hantz Financial Services's 13F filing for Q3 2025, filed 5 Nov 2025.